Skip to content
A.K. Pharma
Home
Products
About
Blogs
Contact
Home
Products
About
Blogs
Contact
A.K. Pharma
BRAF mutated cancer medicine
Meqsel® (Trametinib)
Trametinib 0.5mg, 2mg Tablets — MEK1/2 Inhibitor for BRAF V600-Mutated Metastatic Melanoma, NSCLC, Anaplastic Thyroid Cancer and Metastatic Solid Tumours
Request Quote
Rafinlar® (Dabrafenib)
Dabrafenib 50mg, 75mg Capsules — BRAF V600 Kinase Inhibitor for BRAF V600-Mutated Metastatic Melanoma, NSCLC, Anaplastic Thyroid Cancer and Other BRAF V600E-Mutated Solid Tumours — Used in Combination With Meqsel (Trametinib)
Request Quote
Menu
Home
Products
About
Blogs
Contact
Quote Request Form
Name
Email
Phone
Message
Ask for quote!
Quote Request Form
Name
Email
Phone
Message
Let's get started!